Debt-to-equity of IVERIC bio, Inc. from 30 Jun 2014 to 31 Mar 2023

Taxonomy & unit
ratio: %
Description
Debt-to-equity (D/E) ratio is used to evaluate a company's financial leverage and is calculated by dividing a company's total liabilities by its shareholder equity.
Summary
IVERIC bio, Inc. quarterly Debt-to-equity in % history and change rate from 30 Jun 2014 to 31 Mar 2023.
  • IVERIC bio, Inc. Debt-to-equity for the quarter ending 31 Mar 2023 was 24%, a 160% increase year-over-year.
Debt-to-equity, Quarterly (%)
Debt-to-equity, YoY Quarterly Change (%)

IVERIC bio, Inc. Quarterly Debt-to-equity (%)

Period Value YoY Chg Change % Date
Q1 2023 24% +14% +160% 31 Mar 2023
Q4 2022 18% +6.9% +64% 31 Dec 2022
Q3 2022 12% -0.97% -7.6% 30 Sep 2022
Q2 2022 8% -4.9% -38% 30 Jun 2022
Q1 2022 9% -0.49% -5.1% 31 Mar 2022
Q4 2021 11% +1.7% +18% 31 Dec 2021
Q3 2021 13% +4.5% +54% 30 Sep 2021
Q2 2021 13% +4.6% +55% 30 Jun 2021
Q1 2021 9.5% -1.4% -13% 31 Mar 2021
Q4 2020 9.1% -1.4% -13% 31 Dec 2020
Q3 2020 8.3% -2.1% -20% 30 Sep 2020
Q2 2020 8.2% -41% -83% 30 Jun 2020
Q1 2020 11% -101% -90% 31 Mar 2020
Q4 2019 10% -227% -96% 31 Dec 2019
Q3 2019 10% -597% -98% 30 Sep 2019
Q2 2019 49% -377% -88% 30 Jun 2019
Q1 2019 112% +2072% 31 Mar 2019
Q4 2018 238% +740% 31 Dec 2018
Q3 2018 607% +986% 30 Sep 2018
Q2 2018 427% +792% 30 Jun 2018
Q1 2018 -1959% -1346% -220% 31 Mar 2018
Q4 2017 -502% +1317% +72% 31 Dec 2017
Q3 2017 -379% -2479% -118% 30 Sep 2017
Q2 2017 -365% -1137% -147% 30 Jun 2017
Q1 2017 -613% -1116% -222% 31 Mar 2017
Q4 2016 -1819% -2183% -600% 31 Dec 2016
Q3 2016 2100% +1794% +585% 30 Sep 2016
Q2 2016 772% +516% +201% 30 Jun 2016
Q1 2016 503% +265% +111% 31 Mar 2016
Q4 2015 364% +193% +112% 31 Dec 2015
Q3 2015 307% +191% +166% 30 Sep 2015
Q2 2015 257% +185% +257% 30 Jun 2015
Q1 2015 238% 31 Mar 2015
Q4 2014 171% 31 Dec 2014
Q3 2014 115% 30 Sep 2014
Q2 2014 72% 30 Jun 2014
* An asterisk sign (*) next to the value indicates that the value is likely invalid.